[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.41.181. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
March 1983

Nonspecific Stimulation of Host Defenses Against Bacterial Challenge in Immunosuppressed Mice

Author Affiliations

From the Department of Surgery and the Price Institute of Surgical Research, University of Louisville (Ky) School of Medicine. Dr Galland is now with Hammersmith Hospital, London.

Arch Surg. 1983;118(3):333-337. doi:10.1001/archsurg.1983.01390030065010
Abstract

• Muramyl dipeptide (MDP) has been shown to be a safe and effective host defense stimulant in both normal and malnourished hosts exposed to a bacterial challenge. We investigated its effect in mice compromised by pretreatment with either cyclophosphamide or steroids. The bacterial challenge, designed to simulate a surgical wound infection, consisted of a Klebsiella pneumoniae-laden suture. The MDP treatment resulted in lower local and systemic bacterial spread and increased survival in mice immunosuppressed by cyclophosphamide than in untreated controls. No such effect was demonstrated in animals compromised by steroids. These results suggest that MDP exerts its effect primarily on the macrophage.

(Arch Surg 1983;118:333-337)

References
1.
Ellouz F, Adam A, Ciorbaru R, et al:  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives . Biochem Biophys Res Commun 1974;59:1317-1325.Article
2.
Chedid L, Audibert F, Lefrancier P:  Modulation of the immune response by a synthetic adjuvant and analogs . Proc Natl Acad Sci USA 1976;73:2472-2475.Article
3.
Chedid L, Parant M, Parant F, et al:  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by synthetic immunoadjuvant (N-acetyl-muramyl-L-alanyl-D-isoglutamine) and several analogs . Immunology 1977;74:2089-2093.
4.
Chedid L, Audibert F, Johnson AG:  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents . Prog Allergy 1978;25:63-105.
5.
Polk HC Jr, Calhoun JH, Lowrey LD, et al:  Nonspecific enhancement of host defenses against infection: Experimental evidence of a new order of efficacy and safety . Surgery 1981;90:376-380.
6.
Galland RB, Trachtenberg LS, Rynerson N, et al:  Nonspecific enhancement of resistance to local bacterial infection in starved mice . Arch Surg 1982;117:161-164.Article
7.
Galland RB, Trachtenberg LS, Polk HC Jr:  Nonspecific enhancement of host defenses against infection in malnourished mice . Surg Forum 1981;32:39-41.
8.
Galland RB, Polk HC Jr: Nonspecific stimulation of host defenses against a bacterial challenge in malnourished hosts. Br J Surg, in press.
9.
National Academy of Sciences-National Research Council:  Postoperative wound infections: The influence of ultraviolet irradiation of the operating room and of various other factors . Ann Surg 1964;160( (suppl) ):1-191.Article
10.
Stockman GD, Heim LR, South MA, et al:  Differential effects of cyclophosphamide on the B and T compartments of adult mice . J Immunol 1973;110:277-282.
11.
Turk JL, Parker D:  The effect of cyclophosphamide on the immune response . J Immunopharmacol 1979;1:127-137.Article
12.
Makinodan T, Santos GW, Quinn RP:  Immunosuppresive drugs . Pharmacol Rev 1970;22:189-247.
13.
Grieco MH (ed): Infections in the Abnormal Host . New York, Yorke Medical Books, 1980.
14.
Calhoun K, Trachtenberg L, Hart K, et al:  Corynebacterium parvum: Immunomodulation in local bacterial infections . Surgery 1980;87:53-58.
15.
Kotani S, Watanabe Y, Kinoshita F, et al:  Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or amino acids . Biken J 1975;18: 105-111.
16.
Parant M:  Biologic properties of a new synthetic adjuvant, muramyl dipeptide (MDP) . Springer Semin Immunopathol 1979;2:101-118.Article
17.
Leclerc C, Audibert F, Chedid L:  Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins . Immunology 1978;35:963-970.
18.
Okhuni H, Norose Y, Hayama M, et al:  Adjuvant activities in production of reaginic antibody in mice of bacterial cell wall peptidoglycans or peptidoglycan subunits and of synthetic N-acetyl muramyl dipeptides . Biken J 1979;20:131-140.
19.
Tanaka A, Nagao S, Nagao R, et al:  Stimulation of the reticuloendothelial system of mice by muramyl dipeptide . Infect Immun 1979;24:302-307.
20.
Nagao S, Tanaka A, Yamamoto Y, et al:  Inhibition of macrophage migration by muramyl peptides . Infect Immun 1979;24:308-312.
21.
Sugimura K, Uemiya M, Saiki I, et al:  The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: Evidence of initial target cells for the adjuvant activity . Cell Immunol 1979;43:137-149.Article
22.
Lowy I, Bona C, Chedid L:  Target cells for the activity of a synthetic adjuvant: Muramyl dipeptide . Cell Immunol 1977;29:195-199.Article
23.
Leclerc C, Juy D, Bourgeois E, et al:  In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant: N-acetylmuramyl-L-alanyl-D-isoglutamine, muramyl dipeptide or MDP . Cell Immunol 1979;45:199-206.Article
24.
Fevrier M, Birrien JL, Leclerc C, et al:  The macrophage, target cell of the synthetic adjuvant muramyl dipeptide . Eur J Immunol 1979;8:558-562.Article
25.
Chedid L, Parant M, Parant F, et al:  Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)-poly(L-lysine) carrier . Proc Natl Acad Sci USA 1979;76:6557-6561.Article
26.
Humphries RC, Henika PR, Ferraresi RW, et al:  Effect of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice . Infect Immun 1980;30:462-466.
×